The importance of B cells in SLE has been elucidated by basic research as mentioned above and has been undeniably confirmed in clinical trials in which anti-CD19 chimeric antigen receptor (CAR)-T cell therapy achieved drug-free remission (25–27). Here, CD19 is linked to systemic lupus erythematosus.